N-Methylated pomalidomide
N-methylated pomalidomide (Pomalidomide-methyl), a derivative of Pomalidomide (HY-10984), is a cereblon (CRBN) ligand. N-methylated pomalidomide is unable to recruit CRBN that can be used as a negative control for Pomalidomide. N-methylated pomalidomide can be used to synthesize PROTAC[1].
Product Specifications
CAS Number
[1352827-50-9]
Product Name Alternative
Pomalidomide-methyl
UNSPSC
12352005
Hazard Statement
H302, H312, H332, H361
Target
Ligands for E3 Ligase
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97.86
Smiles
O=C1C2=C(C(N1C3C(N(C)C(CC3)=O)=O)=O)C(N)=CC=C2
Molecular Formula
C14H13N3O4
Molecular Weight
287.27
Precautions
H302, H312, H332, H361
References & Citations
[1]Yokoo H, et al. Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer. ACS Med Chem Lett. 2021 Jan 14;12 (2) :236-241.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cereblon
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Lemur catta NADH-ubiquinone oxidoreductase chain 3 (MT-ND3), partial
ERBB2, phosphorylated (S999) (Erbb2, Kiaa3023, Neu, Receptor tyrosine-protein kinase erbB-2, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, p185erbB2, CD340) (Azide free) (HRP) discontinued
Lentiviral mouse Sertad3 shRNA (UAS) - Lentiviral mouse Sertad3 shRNA (UAS, GFP) (100)